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Rapid μChIP-chip <p>A new method for rapid genome-wide μChIP-chip from as few as 1,000 cells.</p>
Abstract
Genome-wide location analysis of histone modifications and transcription factor binding relies on
chromatin immunoprecipitation (ChIP) assays. These assays are, however, time-consuming and
require large numbers of cells, hindering their application to the analysis of many interesting cell
types. We report here a fast microChIP (μChIP) assay for 1,000 cells in combination with
microarrays to produce genome-scale surveys of histone modifications. μChIP-chip reliably
reproduces data obtained by large-scale assays: H3K9ac and H3K9m3 enrichment profiles are
conserved and nucleosome-free regions are revealed.
Background
Chromatin immunoprecipitation (ChIP) has been widely
used to analyze the location of post-translationally modified
histones or transcription factors in a genome in vivo [1-4].
ChIP analysis of DNA-protein interactions has led to signifi-
cant advances in the understanding of gene regulation and of
how epigenetic phenomena are regulated to affect gene
expression, DNA repair and replication [5,6]. In a typical
ChIP assay, large numbers of cells are used, DNA and pro-
teins are cross-linked and chromatin is sheared to fragments
of approximately 400-500 bp. Antibodies to the protein of
interest are coupled to beads and used to pull down protein-
DNA complexes. Chromatin is eluted from the complexes,
cross-links are reversed and ChIP DNA is purified. A limited
number of genomic sequences associated with the precipi-
tated protein can be identified by PCR. Alternatively, high-
throughput sequencing or hybridization to DNA microarrays
(ChIP-chip) enables genome-scale mapping [7].
The range of biological applications of ChIP assays has been
limited by the requirement for large cell numbers (approxi-
mately 107 cells per immunoprecipitation) and the length of
the procedure (typically 3-5 days). To remedy to these limita-
tions, a few ChIP-PCR strategies have recently been reported.
A 'carrier ChIP' protocol [8] entails immunoprecipitation of
chromatin from 100-1,000 mouse cells by mixing with mil-
lions of Drosophila cells; however, the assay takes several
days and is unsuitable for genome-wide analysis due to excess
of Drosophila carrier DNA that would interfere with such
analysis. A one-day 'fast ChIP' assay [9] simplifies the proce-
dure but has only been demonstrated for large cell samples
and PCR assessment of relatively few loci. We have reported
a downscaled Q2ChIP assay [10] for analysis of multiple pro-
teins in 100,000 cells and, subsequently, a microChIP
(μChIP) protocol [11,12] for as few as 100 cells. Again, how-
ever, only few loci could be examined with these procedures.
Concomitantly, another microChIP assay was reported for
10,000-100,000 cells, which allows genome-wide analysis by
ChIP-chip [13]. This assay represents an advancement in
ChIP applications, but it remains labor intensive, takes over 4
days and has been validated for 100,000 cells and the top
30% of enriched promoters only. Except for this single
attempt to downscale the genome-wide approach, ChIP-chip
typically starts out with 107-108 cells and yields amplified
DNA ready for labeling and hybridization after 4-5 days. Our
ultimate goal is to enable genome-scale investigation of his-
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tone modifications in very small cell samples, such as sorted
stem cell populations, human tumor biopsies and embryonic
cells. Therefore, we wished to move beyond these limitations,
reduce the cell numbers and time required, and enhance the
robustness of the assay.
We report here the optimization and validation of a one-day
μChIP assay that enables genome-wide surveys of epigenetic
histone modifications from 1,000 cells using microarrays.
Typically, reliable resolution of ChIP location analysis is
ensured through gel electrophoresis assessment of a sample
of the fragmented chromatin to determine average DNA frag-
ment length. However, this would require many more cells
than what we used in this study. Thus, we devised a PCR-
based approach and formulated an equation to allow an esti-
mation of chromatin fragmentation in small cell samples, a
step critical for reliable resolution of μChIP-chip analysis.
Using μChIP-chip, we investigated the enrichment, on pro-
moter regions, of acetylated lysine 9 and trimethylated lysine
9 of histone H3 (H3K9ac and H3K9m3, respectively) associ-
ated with transcriptionally active and silent promoters [14].
Four distinct classes of genes were identified based on differ-
ential marking by these modifications. μChIP-chip also dem-
onstrates a nucleosome-free region immediately upstream of
the transcription start site (TSS) for active genes, and shows
that silenced genes exhibit a more closed chromatin confor-
mation. Furthermore, construction of a metagene and corre-
lation analysis reveal mutually exclusive occupancy profiles
for H3K9ac and H3K9m3.
Results and discussion
Optimization and validation of μChIP-chip
We established and validated μChIP-chip (Figure 1) by moni-
toring promoter association of H3K9ac and H3K9m3. These
modifications were immunoprecipitated from pluripotent
human embryonal carcinoma NCCIT cells by large scale
Q2ChIP or by μChIP (1,000 cells). Notably, we set up a quan-
titative PCR (qPCR) approach and formulated an equation
that enables assessment of chromatin fragmentation in small
cell samples within a range of DNA fragment sizes suitable for
ChIP. This was critical to ensure proper resolution of μChIP-
chip analysis and, to our knowledge, is the only strategy to
overcome this task with small cell numbers. Plotting average
DNA fragment length against qPCR signal intensities from
large scale sonicated samples reveals a linear relationship
within the examined range (300-600 bp) of fragmentation
(Additional data file 1). This is a useful average fragment size
window for most ChIP applications. The linear relationship is
described through the equation (y = 0.0012x - 0.0059), where
y is the relative PCR signal intensity of the sample and × is the
average DNA fragment length (Additional data file 1). Start-
ing with 1,000 cells, sonication regimes of 3 × 30 s resulted in
a relative PCR signal intensity of 0.502. The equation esti-
mates an average DNA fragment length of approximately 420
bp; hence, this condition is suited for μChIP-chip analysis.
Average fragment size was validated by agarose gel electro-
phoresis (Additional data file 1).
As part of the optimization of μChIP-chip, we carried out a
comparison of different ChIP DNA isolation procedures. The
phenol-chloroform isoamylalcohol DNA extraction method
used in this study proved superior to the MinElute (QIAgen,
Valencia, CA, USA; catalogue number 28004) and NucleoS-
pin Extract II (Machery-Nagel, Bethlehem, PA, USA; cata-
logue number 740609.10) DNA purification columns in that
it recovered two to three times more DNA than the commer-
cial kits, as determined by qPCR (data not shown). Hence, it
enables a two- to three-fold further reduction in cell numbers
Flow chart of the μChIP-chip procedure Figure 1
Flow chart of the μChIP-chip procedure.
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for μChIP-chip relative to the commercial kits. Furthermore,
an RNase digestion step was tailored to the fast downscaled
ChIP procedure to remove RNA that would otherwise inter-
fere with downstream amplification and array hybridization.
Subsequently, DNA amounts in ChIP and input samples were
measured with a Qubit fluorometer (Additional data file 2) to
aid in determining the ChIP-DNA amplification conditions.
DNA amount recovered from Q2ChIP inputs averaged 1,080
ng whereas μChIP inputs averaged 6.9 ng. These measure-
ments were in line with an estimated DNA content of 6.6 pg
per cell [15,16]. Q2ChIP recovered 3.2% and 4.3% of input
DNA with antibodies to H3K9ac and H3K9m3, respectively
(Additional data file 2). Higher recovery was observed with
antibodies against H3K9m2 and H3K4m3 (data not shown),
arguing that μChIP-chip is likely to also be effective with anti-
bodies to other modified histones, which precipitate at least
as well as those used here. DNA amounts in μChIP samples
were estimated from Q2ChIP DNA recoveries and μChIP
input to get a hint of the amount used for whole genome
amplification (WGA). As determined by the assessed DNA
amounts, Q2ChIP samples and inputs were amplified with the
WGA2 kit (Sigma-Aldrich, St. Louis, MO, USA) whereas the
WGA4 kit, optimized for very little DNA, was used for μChIP
DNA amplification.
To assess the validity of small cell number ChIP-chip and the
reproducibility of this assay, correlation analysis of log2 ChIP/
input ratios between Q2ChIP-chip and μChIP-chip, and
between replicates, was carried out with values resulting from
Maxfour calculations [17]. This algorithm scores each pro-
moter by finding the highest average log2ratio among ten con-
secutive probes per tiled region ('MaxTen'). To fully validate
μChIP-chip, correlation analysis was carried out with Max-
Ten scores for all tiled regions, as opposed to the reported top
30% enriched promoters in an earlier study [13]. Both
H3K9ac and H3K9m3 μChIP-chips robustly reproduced the
large scale results (R = 0.80-0.94; Figure 2a). We then com-
pared results from μChIP-chip biological replicates with each
antibody to demonstrate high reproducibility (Figure 2b).
Moreover, comparison between H3K9ac and H3K9m3 Max-
Ten values showed no correlation when assessed by large
scale or μChIP-chip (data not shown), as expected from the
mutually exclusive occupancy of these modifications.
μChIP-chip and Q2ChIP-chip enrichment profiles for 
H3K9ac and H3K9m3
Examples of normalized log2 ChIP/input signal ratios for two
segments of chromosome 12 are shown in Figure 3a. For both
H3K9ac and H3K9m3, the data show high similarity of
enrichment profiles between μChIP-chip and Q2ChIP-chip,
and high reproducibility of profiles between μChIP-chip rep-
licates (Figure 3a). A detailed view of log2 ratios for tiled
regions selected for their enrichment in either H3K9ac
(POU5F1 and SOX2 promoters), H3K9m3 (TRIM40), both
marks (promoter and exon 1 of NANOG), or none of these
marks (ESR1), illustrates the high similarity of enrichment
profiles also within a tiled region, and confirms the reproduc-
ibility between the two methods (Figure 3b). H3K9ac and
H3K9m3 peaks detected with a false discovery rate (FDR) of
≤ 0.05 robustly overlapped between both ChIP assays (Figure
3b, red areas). Note, however, that due to limitations in the
peak-calling software, the exact position of a peak may vary
from array to array, and a broad peak may be called as a mul-
tiple peaks [17].
Verification of μChIP-chip data by quantitative PCR
qPCR analysis of WGA-amplified μChIP DNA and non-ampli-
fied Q2ChIP DNA verified the array data (Figure 4). As
expected from their expression in NCCIT cells, the POU5F1,
NANOG and SOX2 promoters were acetylated on H3K9 in the
absence of H3K9m3. The UBE2B  housekeeping promoter
was enriched in H3K9ac but not in H3K9m3, similarly to
KNTC1 and FLJ11021, also expressed in NCCIT cells. Con-
versely, promoters of genes not expressed in NCCIT cells were
either enriched in H3K9m3 without H3K9ac (TSH2B, H1t,
ZNF323, KCNA1, TRIM40) or enriched in neither H3K9m3
nor H3K9ac (LDHC, ESR1, OXT, GPR109A) (Figure 4). Alto-
gether, the data show that: promoters examined are enriched
in either H3K9ac, H3K9m3 or none of these modifications,
but not in both; active promoters are marked by H3K9ac in
the absence of H3K9m3; and inactive promoters are marked
by either H3K9m3 in the absence of H3K9ac, or by none of
these marks, supporting the existence of both H3K9m3-
dependent and independent gene repression mechanisms
[18].
Metagene analysis of H3K9ac and H3K9m3 enrichment
We next compared the average promoter enrichment profiles
for H3K9ac and H3K9m3 over 2.7 kb within the tiled regions
in large-scale ChIP-chip, and determined whether these pro-
files were maintained in μChIP-chip. We created a composite
metagene from the collection of genes enriched (by the detec-
tion of one or more peaks with FDR ≤ 0.05; see Materials and
methods) within the tiled region in either H3K9ac or
H3K9m3 by Q2ChIP-chip. These two sets of genes were the
basis for similar metagene analysis of μChIP-chip enrich-
ment. Analysis of modified histone occupancy by large scale
assays revealed distinct enrichment profiles for acetylated
and trimethylated H3K9 (Figure 5a). H3K9ac showed a bimo-
dal distribution with a pronounced dip immediately
upstream of the TSS, suggesting a nucleosome-free region for
active genes, as marked by acetylation; in contrast, H3K9m3
was more evenly distributed across the regions examined,
with most prominent enrichment in the upstream half of the
region and only a slight decrease in signal intensity around
the TSS (Figure 5a). These profiles were rigorously conserved
in μChIP-chip, both when we examined the same genes found
to be enriched by either modification by Q2ChIP (Figure 5b),
and when we examined all genes enriched in H3K9ac or
H3K9m3 based on μChIP peak detection (data not shown).
These findings support evidence that transcribed genes have
a nucleosome-free region immediately upstream of the TSS,http://genomebiology.com/2009/10/2/R13 Genome Biology 2009,     Volume 10, Issue 2, Article R13       Dahl et al. R13.4
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whereas most transcriptionally silenced genes do not [19].
H3K9m3-marked genes that lack a nucleosome-free region
immediately 5' of the TSS may belong to a group of silent
genes that do not recruit a pre-initiation complex, as the
absence of pre-initiation complex recruitment in unexpressed
genes has been shown to coincide with a lack of nucleosome
depletion [20]. Members of a second and smaller group of
silent genes do recruit a pre-initiation complex [20], and may
be repressed by an H3K9m3-independent mechanism.
Distinct classes of genes based on differential enrichment in
H3K9ac and H3K9m3 were evidenced by metagene profiles
from  μChIP-chip data on genes solely enriched in either
H3K9ac (Figure 6a, left panel), H3K9m3 (Figure 6a, right
panel) or both (Figure 6b) within the tiled region. Addition-
ally, in concordance with the qPCR data, we identified a
fourth group of genes not enriched in either of these modifi-
cations. We also found two groups of genes marked by
H3K9ac: those devoid of H3K9m3 (Figure 6a, left panel) and
Reproducibility and specificity of μChIP-chip Figure 2
Reproducibility and specificity of μChIP-chip. (a) Two-dimensional scatter plots comparing μChIP-chip with Q2ChIP-chip using antibodies to H3K9ac and 
H3K9m3. (b) Comparison of two μChIP-chip experiments using antibodies to H3K9ac and H3K9m3. MaxTen values from each experiment are plotted on 
a log2 scale.
R=0.81
H3K9m3 ChIP
P
I
h
C
2
Q
3
m
9
K
3
H
3
3
2
2
1
1
0
0
-1
-1
R=0.89
H3K9ac ChIP-1
c
a
9
K
3
H2
-
P
I
h
C
3
3
2
2
1
1
0
0
-1
-1
R=0.94
H3K9ac ChIP
P
I
h
C
2
Q
c
a
9
K
3
H
4
3
3
2
2
1
1
0
0
-1
-1 -2
R=0.81
H3K9m3 ChIP-1
3
m
9
K
3
H
2
-
P
I
h
C
3 2 1 0 -1
2
1
0
-1
(a) (b)http://genomebiology.com/2009/10/2/R13 Genome Biology 2009,     Volume 10, Issue 2, Article R13       Dahl et al. R13.5
Genome Biology 2009, 10:R13
Enrichment profiles for H3K9ac and H3K9m3 expressed as log2 ChIP/input ratios in Q2ChIP-chip and μChIP-chip assays Figure 3
Enrichment profiles for H3K9ac and H3K9m3 expressed as log2 ChIP/input ratios in Q2ChIP-chip and μChIP-chip assays. (a) Comparison of enrichment 
profiles over a 360-kb region (H3K9ac) and a 300-kb region (H3K9m3) of chromosome 12 obtained by Q2ChIP-chip and in two μChIP-chip replicates. (b) 
Detailed profiles of H3K9ac and H3K9m3 enrichment on the 3-kb tiled regions (shown in bottom panels) of the POU5F1, NANOG, SOX2, TRIM40 and 
ESR1 promoters. Log2 ChIP/input ratios are shown in black and H3K9ac or H3K9m3 peaks (FDR ≤ 0.05) are superimposed (shaded in red). Tiled regions 
(bottom panel) also show the region examined by ChIP-qPCR (blue bars) in Figure 4.
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those also enriched in H3K9m3 primarily upstream of the
acetylated region (Figure 6b). Examination of individual
genes confirmed the distribution of each mark throughout the
tiled regions. H3K9m3 profiles also appear different based on
the analyzed set of genes. Genes solely enriched in H3K9m3
display a relatively even distribution of this modification (Fig-
ure 6a, right panel), whereas genes also marked by H3K9ac
show lower levels of H3K9m3 in the 3' half of the assessed
region (Figure 6b). Metagene analysis of genes harboring
both H3K9ac and H3K9m3 peaks within the tiled region
reveals mutually exclusive occupancy profiles for these
marks, and predominantly contain trimethylation upstream
of the region marked by acetylation (Figure 6b). It will be
interesting to investigate whether differential marking of
genes by H3K9ac and H3K9m3 has implications on tran-
scriptional regulation and hierarchy [21-23].
Conclusion
Our results demonstrate that fast genome-scale analysis of
promoter occupancy by modified histones is possible from as
few as 1,000 cells. This represents an improvement over pre-
vious ChIP-chip protocols, which require significantly more
cells and take at least 4 days up to hybridization [13,24]. Spe-
cific steps of the Acevedo et al. [13] microChIP protocol that
differ from our μChIP-chip assay are detailed in Additional
data file 3. Although performant, in its current form μChIP-
chip has limitations. First, we cannot formally exclude that
the DNA amplification step does not introduce bias. A recent
comparison of three widely used amplification procedures,
including WGA, reports that all procedures introduce some
bias [25]. Notably however, WGA-based amplification
resulted in the most accurate performance. We show here by
qPCR that amplification of ChIP DNA from 1,000 cells intro-
duces little bias; however, when establishing μChIP-chip,
amplification of DNA from 100 cells produced inconsisten-
cies, presumably due to lower signal/noise ratios [12] and
more rounds of amplification were required owing to the
minute amount of template DNA used. Development of
improved amplification protocols may result in successful
application of μChIP-chip to fewer than 1,000 cells. Secondly,
μChIP-chip may also be suitable for non-histone proteins,
although this remains to be tested. For analysis of low-abun-
dance or transiently bound proteins, cell numbers might need
to be increased compared to histone μChIP-chip. Further, we
formulate an equation that allows an estimation of the aver-
age DNA fragment length produced by sonication of chroma-
tin from minute cell samples. It is imperative to assess
chromatin fragmentation prior to ChIP location analysis to
ensure good resolution and valid analysis. To our knowledge,
this is the only strategy to overcome this task with small cell
numbers. Moreover, array data show high reproducibility
between biological replicates and conservation of H3K9ac
and H3K9m3 enrichment profiles in the large scale and
μChIP-chip assays. We demonstrate that μChIP-chip can be
applied to reveal nucleosome-free regions in as few as 1,000
cells. In addition, metagene analysis reveals distinct occu-
pancy profiles for each histone modification in the tiled
regions, which are maintained in μChIP-chip, and identify
four distinct groups of genes in human embryonal carcinoma
cells.  μChIP-chip therefore makes genome-wide epigenetic
analyses amenable to small cell samples, such as rare stem
cell subpopulations, cells from the early embryo or human
biopsies.
Materials and methods
Materials
Pluripotent human embryonal carcinoma NCCIT cells were
cultured as described [10]. Antibodies against H3K9ac were
from Upstate (Millipore Inc., Billerica, MA, USA; catalogue
number 06-942) and antibodie s  t o  H 3 K 9 m 3  w e r e  f r o m
Diagenode (Liège, Belgium; catalogue number pAb-056-
050). All other reagents were from Sigma-Aldrich unless oth-
erwise indicated.
ChIP assays
The Q2ChIP assay, referred to as large scale ChIP, was per-
formed as described [10]. Chromatin was prepared from 2 ×
106 cells, diluted to 2 A260 units and aliquoted into 100 μl per
ChIP.
ChIP-qPCR analysis of H3K9ac and H3K9m3 association with the tiled  regions of indicated genes Figure 4
ChIP-qPCR analysis of H3K9ac and H3K9m3 association with the tiled 
regions of indicated genes. Experiments are based on the same cell 
batches as those examined by microarray. Data are expressed as log2 of 
fold-enrichment relative to input (mean ± standard deviation) in three 
independent experiments. Promoter regions covered by amplicons are 
shown in Figure 3b, bottom panels. The expression pattern of each gene 
was determined in duplicate transcriptome analysis of NCCIT cells using 
Affymetrix U133A GeneChips (not shown).
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μChIP was carried out from 1,000 cells per ChIP [11,12] with
modifications and optimization to enable genome-wide anal-
ysis. A troubleshooting guide is presented in Additional data
file 4. Primary antibodies (2.4 μg) were coupled to Dynabeads
Protein A (10 μl; Dynal Biotech, Invitrogen, Oslo, Norway) in
RIPA buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.5mM
EGTA, 1% Triton X-100, 0.1% SDS, 0.1% Na-deoxycholate,
140 mM NaCl) for 2 h at 4°C. Tubes were in strips handled in
a magnetic rack (Diagenode, catalogue number kch-816-
0 0 1 ) .  C o n c o m i t a n t l y ,  c e l l s  w e r e  d e t a c h e d  b y  a  f e w  s h a r p
blows to the flask in the presence of 20 mM of the histone
deacetylase inhibitor sodium butyrate, and aliquots of 1,000
cells were suspended in 500 μl phosphate-buffered saline/
butyrate. Proteins and DNA were cross-linked with 1% for-
maldehyde for 8 minutes and cross-linking was stopped with
125 mM glycine. Cells were centrifuged at 620 g in a swing-
out rotor for 10 minutes at 4°C and washed twice in 0.5 ml ice-
cold phosphate-buffered saline/butyrate by gentle vortexing
and centrifugation as above. Approximately 20 μl buffer was
left with the pellet after removal of the last wash. Cells were
lysed by addition of 120 μl room temperature lysis buffer (50
mM Tris-HCl, pH 8, 10 mM EDTA, 1% SDS, protease inhibi-
tor cocktail (Sigma-Aldrich, catalogue number P8340), 1 mM
PMSF, 20 mM butyrate) and thorough vortexing. Following a
3-minute incubation on ice and additional vortexing, nuclei
were centrifuged at 860 g for 10 minutes and the supernatant
discarded, leaving approximately 20 μl lysis buffer in the
tube. RIPA buffer (120 μl containing protease inhibitor cock-
tail, 1 mM PMSF, 20 mM butyrate) was added, the tube was
vortexed thoroughly and cells sonicated for 3 × 30 s on ice
with 30 s pauses, using a probe sonicator (Labsonic-M, 3-mm
probe; cycle 0.5, 30% power; Sartorius AG, Göttingen, Ger-
Metagene analysis of the distribution of H3K9ac and H3K9m3 in Q2ChIP-chip and μChIP-chip assays Figure 5
Metagene analysis of the distribution of H3K9ac and H3K9m3 in Q2ChIP-chip and μChIP-chip assays. H3K9ac and H3K9m3 occupancy profiles detected by 
(a) Q2ChIP-chip and (b) μChIP-chip in the 2.7 kb tiled regions. In (b), the same genes showing enrichment in either mark by Q2ChIP-chip (genes shown in 
(a)) were included in the analysis.
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many) to produce fragments of approximately 400-500 bp.
The sample was centrifuged at 12,000 g for 10 minutes at 4°C
and the supernatant was transferred into a 0.2-ml PCR tube
containing beads pre-incubated with antibodies, leaving
approximately 10 μl of supernatant behind. A chromatin sam-
ple identical to that used in the ChIP sample was prepared to
represent the input and transferred into a 1.5 ml tube.
Proper chromatin fragmentation from 1,000 cells was
ensured using a qPCR assay further developed from that pre-
viously described [12]. Since the reliability of ChIP depends
on control of chromatin fragmentation, we accomplished this
for our genome-scale location analysis by formulating an
equation that enables an estimation of average fragment
length in minute cell samples. A linear relationship between
average DNA fragment length and qPCR signal intensities
within a fragmentation range useful for ChIP (300-600 bp)
was described through this equation, which allows calcula-
tion of DNA fragment length after experimental determina-
tion of the relative PCR signal in a sonicated 1,000-cell
sample (Additional data file 1).
Immunoprecipitation and washes of the ChIP product were
performed essentially as described [12]. Beads were released
into the chromatin suspension and rotated at 40 rpm for 2 h
at 4°C. The ChIP material was washed three times by 4-
minute incubations in 100 μl of RIPA buffer and once in 100
μl of 10 mM Tris-HCl, pH 8.0, 10 mM EDTA (TE) buffer, and
transferred into a new tube while in TE buffer. Elution buffer
(20 mM Tris-HCl, pH 7.5, 5 mM EDTA, 20 mM butyrate, 50
mM NaCl, 1% SDS) (150 μl) and 5 μg RNase (Roche, Basel,
Switzerland; catalogue number 11119915001) were added
after removal of TE buffer. The same amount of RNase was
added to the input, and ChIP and input samples were incu-
bated at 37°C for 20 minutes on a Thermomixer (1,300 rpm;
Eppendorf, Hamburg, Germany). Samples were briefly cen-
μChIP-chip identifies differential enrichment in H3K9ac and H3K9m3 Figure 6
μChIP-chip identifies differential enrichment in H3K9ac and H3K9m3. (a) H3K9ac and H3K9m3 occupancy profiles detected by μChIP-chip on tiled 
regions with peaks in H3K9ac only (left) and H3K9m3 only (right). Genes containing at least one peak in H3K9m3 or H3K9ac, respectively, were removed 
from the analysis. (b) H3K9ac and H3K9m3 occupancy profiles exclusively on tiled regions containing both marks.
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trifuged, 1 μl of proteinase K (at 20 μg/μl) was added and tube
lids were replaced by new ones to prevent leakage resulting
from softening of the plastic upon heating. DNA elution,
cross-link reversal and proteinase K digestion were carried
out in a single step for 2 h at 68°C on a Thermomixer. After
capturing of beads, the supernatant was recovered, beads
were incubated for another 5 minutes in 150 μl elution buffer
containing 50 μg / m l  p r o t e i n a s e  K ,  and both supernatants
were pooled. ChIP and input samples were made up to a final
volume of 490 μl in elution buffer without SDS. ChIP DNA
was extracted with phenol-chloroform isoamylalcohol and
chloroform isoamylalcohol, ethanol-precipitated in the pres-
ence of 10 μl acrylamide carrier (Sigma-Aldrich, catalogue
number A9099) and dissolved in 10 μl MilliQ water.
Whole genome amplification and clean up of ChIP 
DNA
ChIP and input DNA were amplified with WGA2 (Q2ChIP) or
WGA4 (μChIP) GenomePlex Whole Genome Amplification
Kits (Sigma-Aldrich) as per the manufacturer's instructions;
however, we omitted the lysis and DNA fragmentation steps.
Starting from step 6 in the WGA procedures, library prepara-
tion was carried out and immediately followed by amplifica-
tion for 14 or 25 cycles for Q2ChIP and μChIP, respectively.
Amplified DNA was cleaned up using the QIAquick PCR puri-
fication kit (Qiagen, catalogue number 28104) as per the
manufacturer's instructions except that five volumes of buffer
PB (Qiagen, catalogue number 19066) were used instead of
buffer PBI to ensure the absence of pH indicator in the sample
(the pH indicator in buffer PBI may interfere with microarray
applications). Furthermore, DNA was eluted in 30 μl 1 mM
Tris-HCl, pH 8.0. The kit is designed for purification of DNA
fragments of 100-10,000 bp, and thus was well suited for
ChIP and input DNA fragments. Following DNA purification,
samples were quantified by NanoDrop (NanoDrop Technolo-
gies, Wilmington, DE, USA) and aliquots were diluted to 7.5
ng/μl in TE buffer for PCR-based quality assessment. Impor-
tantly, parallel ChIP experiments were carried out without
amplification and were directly assessed by qPCR to serve as
a reference for amplified samples as well as for array data.
Quality of amplified samples was also evaluated by agarose
gel electrophoresis. Typically, amplification produced 7.5-15
μg DNA (depending on the WGA kit lot number) with an aver-
age size of approximately 400-500 bp. WGA amplification
can therefore yield enough DNA to probe as many as seven
arrays without further amplification.
DNA labeling and array hybridization
ChIP and input DNA fragments were labelled with Cy5 and
Cy3, respectively, and hybridized onto Nimblegen human
HG18 RefSeq Promoter arrays. Arrays covered approximately
27,000 human RefSeq promoters, ranging from -2,200 to
+500 bp relative to the transcription start site (TSS). Probes
consisted of 385,000 50- to 75-mers tiled throughout non-
repetitive genomic sequences at a median spacing of 100 bp.
Sequence source for probes was the UCSC Genome Browser.
ChIP and input DNA labeling, hybridization and detection
were performed using the services of Nimblegen (Madison,
WI, USA).
Data analysis
Signal intensity data were extracted from the scanned images
of each array using NimbleScan software. Log2 ChIP/input
ratios were scaled and centered around zero by subtracting
the bi-weight mean for the log2 ratio values for all features on
the array from each log2 ratio value. Peaks were detected by
searching for four or more probes with a signal above a cut-off
value using a 500-bp sliding window. Cut-off values were a
percentage of a hypothetical maximum defined as (mean + 6
[standard deviation]). Ratio data were randomized 20 times
to evaluate the probability of false positives, and each peak
was assigned a FDR score. Normalization and peak detection
were performed by Nimblegen in accordance with their pro-
tocols. This process uses a cut-off range of 90% to 15%, with
higher cut-offs corresponding to more stringent peak detec-
tion, as reflected in the FDR calculation. The Nimblegen pro-
tocol was recently evaluated as part of a comprehensive study
that objectively analyzed the performance of a number of
commercially available ChIP-chip array platforms and signal
detection algorithms [26], and found to deliver reliable
results.
For scoring the promoters before correlation analysis, we
assigned an amplification value to each promoter by applying
the Maxfour algorithm with a ten-probe window [27]. For
each promoter, the corresponding probes' log2 ratios were
scanned in genome order with a ten-probe window. The high-
est ten-probe average was used as the amplification value for
the promoter. Promoters represented by less then ten probes
(1.5% of the total) were not included in the analysis.
Metagene analysis of regions containing H3K9ac or 
H3K9m3
Metagene analysis of promoter occupancy was performed
essentially as described [28]. Genes with a high probability of
enrichment (FDR ≤ 0.05) in H3K9ac or H3K9m3 marks
within the tiled region were collected and used to assemble a
metagene of the average composite binding. Each region was
interrogated for probes and these were mapped into a 2.7-kb
wide window at the appropriate offsets based on strand orien-
tation. Linear interpolation was used to estimate the fold
enrichment at each base position within the 2.7-kb window.
This interpolation left the 5' and 3' ends of the window under-
represented. The metagene was created from this collection
of functions by calculating the mean of the values mapped to
each position by all the regions found to be enriched in
H3K9ac or H3K9m3 Q2ChIP or μChIP. If the offset corre-
sponded to the exact location of a probe within a specific tiled
region, values were directly measured; if not, values were lin-
early interpolated from the values of the two flanking probes
[28]. Genes solely enriched by only one of the examinedhttp://genomebiology.com/2009/10/2/R13 Genome Biology 2009,     Volume 10, Issue 2, Article R13       Dahl et al. R13.10
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marks were selected from the entire set of genes harboring
the mark (peak detection with FDR ≤ 0.05) and then remov-
ing from that set all genes also possessing a peak for the other
mark.
Quantification of non-amplified ChIP DNA
Because the NanoDrop spectrophotometer does not allow
accurate quantification of minute amounts of non-amplified
ChIP DNA, we used a Qubit fluorometer (Invitrogen,
Carlsbad, CA, USA; catalogue number Q32857) and a Quant-
iT dsDNA HS kit (Invitrogen, catalogue number Q32851) for
quantification. Ten percent of Q2ChIP DNA samples and
whole μChIP inputs were mixed with Quant-iT working solu-
tion to a final volume of 200 μl, incubated for 2 minutes and
analyzed by the Quant-iT DNA HS program on a Qubit fluor-
ometer.
Quantitative PCR
Immunoprecipitated DNA from three independent ChIPs
was analyzed by duplicate qPCR [10] (Additional data file 5).
qPCR data are expressed as mean (± standard deviation) log2
values of enrichment relative to input DNA.
Abbreviations
ChIP: chromatin immunoprecipitation; FDR: false discovery
rate; H3K9ac: acetylated lysine 9 of histone H3; H3K9m3: tri-
methylated lysine 9 of histone H3; μChIP: microChIP; qPCR:
quantitative PCR; TSS: transcription start site; WGA: whole-
genome amplification.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a figure describ-
ing the steps behind the equation formulated to estimate,
using qPCR, chromatin fragment length after a given sonica-
tion regime of 1,000 cells. Additional data file 2 a table pro-
viding values of DNA recovery from Q2ChIP and μChIP.
Additional data file 3 is information on a technical compari-
son between μChIP-chip and a previously published protocol.
Additional data file 4 is a troubleshooting guide for μChIP-
chip. Additional data file 5 is a table listing ChIP qPCR prim-
ers used in this study.
Additional data file 1 Steps behind the equation formulated to estimate chromatin frag- ment length after a given sonication regime of 1,000 cells Steps behind the equation formulated to estimate, using qPCR,  chromatin fragment length after a given sonication regime of 1,000  cells. Click here for file Additional data file 2 DNA recovery from Q2ChIP and μChIP DNA recovery from Q2ChIP and μChIP. Click here for file Additional data file 3 Technical comparison between μChIP-chip and a previously pub- lished protocol Technical comparison between μChIP-chip and a previously pub- lished protocol. Click here for file Additional data file 4 Troubleshooting guide for μChIP-chip Troubleshooting guide for μChIP-chip. Click here for file Additional data file 5 ChIP qPCR primers used in this study ChIP qPCR primers used in this study. Click here for file
Acknowledgements
This work was supported by the FUGE, YFF, STAMCELLER and STOR-
FORSK programs of the Research Council of Norway, and by the Norwe-
gian Cancer Society.
References
1. Dedon PC, Soults JA, Allis CD, Gorovsky MA: Formaldehyde
cross-linking and immunoprecipitation demonstrate devel-
opmental changes in H1 association with transcriptionally
active genes.  Mol Cell Biol 1991, 11:1729-1733.
2. Hebbes TR, Clayton AL, Thorne AW, Crane-Robinson C: Core his-
tone hyperacetylation co-maps with generalized DNase I
sensitivity in the chicken β-globin chromosomal domain.
EMBO J 1994, 13:1823-1830.
3. O'Neill LP, Turner BM: Immunoprecipitation of chromatin.
Methods Enzymol 1996, 274:189-197.
4. Solomon MJ, Larsen PL, Varshavsky A: Mapping protein-DNA
interactions in vivo with formaldehyde: evidence that histone
H4 is retained on a highly transcribed gene.  Cell 1988,
53:937-947.
5. Bernstein BE, Meissner A, Lander ES: The mammalian epige-
nome.  Cell 2007, 128:669-681.
6. Bird A: Perceptions of epigenetics.  Nature 2007, 447:396-398.
7. Collas P, Dahl JA: Chop it, ChIP it, check it: the current status
of chromatin immunoprecipitation.  Front Biosci 2008,
13:929-943.
8. O'Neill LP, Vermilyea MD, Turner BM: Epigenetic characteriza-
tion of the early embryo with a chromatin immunoprecipita-
tion protocol applicable to small cell populations.  Nat Genet
2006, 38:835-841.
9. Nelson JD, Denisenko O, Sova P, Bomsztyk K: Fast chromatin
immunoprecipitation assay.  Nucleic Acids Res 2006, 34:e2.
10. Dahl JA, Collas P: Q2 ChIP, a quick and quantitative chromatin
immunoprecipitation assay unravels epigenetic dynamics of
developmentally regulated genes in human carcinoma cells.
Stem Cells 2007, 25:1037-1046.
11. Dahl JA, Collas P: MicroChIP - A rapid micro chromatin immu-
noprecipitation assay for small cell samples and biopsies.
Nucleic Acids Res 2008, 36:e15.
12. Dahl JA, Collas P: A rapid micro chromatin immunoprecipita-
tion assay (μChIP).  Nat Protoc 2008, 3:1032-1045.
13. Acevedo LG, Iniguez AL, Holster HL, Zhang X, Green R, Farnham PJ:
Genome-scale ChIP-chip analysis using 10,000 human cells.
Biotechniques 2007, 43:791-797.
14. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA: Histone H3
lysine 9 methylation and HP1gamma are associated with
transcription elongation through mammalian chromatin.
Mol Cell 2005, 19:381-391.
15. Hess HH, Thalheimer C: DNA and RNA and the cytoarchitec-
ture of human frontal cortex.  J Neurochem 1971, 18:1281-1290.
16. Forslund O, Antonsson A, Higgins G, Ly H, Delius H, Hunziker A, de
Villiers EM: Nucleotide sequence and phylogenetic classifica-
tion of candidate human papilloma virus type 92.  Virology
2003, 312:255-260.
17. O'Geen H, Nicolet CM, Blahnik K, Green R, Farnham PJ: Compari-
son of sample preparation methods for ChIP-chip assays.  Bio-
techniques 2006, 41:577-580.
18. Kouzarides T: Chromatin modifications and their function.
Cell 2007, 128:693-705.
19. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey
TS, Crawford GE: High-resolution mapping and characteriza-
tion of open chromatin across the genome.  Cell 2008,
132:311-322.
20. Ozsolak F, Song JS, Liu XS, Fisher DE: High-throughput mapping
of the chromatin structure of human promoters.  Nat Biotech-
nol 2007, 25:244-248.
21. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guen-
ther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA,
Jaenisch R, Young RA: Core transcriptional regulatory circuitry
in human embryonic stem cells.  Cell 2005, 122:947-956.
22. Kim J, Chu J, Shen X, Wang J, Orkin SH: An extended transcrip-
tional network for pluripotency of embryonic stem cells.  Cell
2008, 132:1049-1061.
23. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G,
George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD,http://genomebiology.com/2009/10/2/R13 Genome Biology 2009,     Volume 10, Issue 2, Article R13       Dahl et al. R13.11
Genome Biology 2009, 10:R13
Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL,
Ruan Y, Lim B, Ng HH: The Oct4 and Nanog transcription net-
work regulates pluripotency in mouse embryonic stem cells.
Nat Genet 2006, 38:431-440.
24. Lee TI, Johnstone SE, Young RA: Chromatin immunoprecipita-
tion and microarray-based analysis of protein location.  Nat
Protoc 2006, 1:729-748.
25. Ponzielli R, Boutros PC, Katz S, Stojanova A, Hanley AP, Khosravi F,
Bros C, Jurisica I, Penn LZ: Optimization of experimental design
parameters for high-throughput chromatin immunoprecipi-
tation studies.  Nucleic Acids Res 2008, 36:e144.
26. Johnson DS, Li W, Gordon DB, Bhattacharjee A, Curry B, Ghosh J,
Brizuela L, Carroll JS, Brown M, Flicek P, Koch CM, Dunham I, Bieda
M, Xu X, Farnham PJ, Kapranov P, Nix DA, Gingeras TR, Zhang X,
Holster H, Jiang N, Green RD, Song JS, McCuine SA, Anton E, Nguyen
L, Trinklein ND, Ye Z, Ching K, Hawkins D, et al.: Systematic eval-
uation of variability in ChIP-chip experiments using prede-
fined DNA targets.  Genome Res 2008, 18:393-403.
27. Acevedo LG, Bieda M, Green R, Farnham PJ: Analysis of the mech-
anisms mediating tumor-specific changes in gene expression
in human liver tumors.  Cancer Res 2008, 68:2641-2651.
28. Wardle FC, Odom DT, Bell GW, Yuan B, Danford TW, Wiellette EL,
Herbolsheimer E, Sive HL, Young RA, Smith JC: Zebrafish pro-
moter microarrays identify actively transcribed embryonic
genes.  Genome Biol 2006, 7:R71.